T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1/IL-12 engineered probiotics
Cell Reports · 2024-04 · 43 (4) · 114086
DOI: 10.1016/j.celrep.2024.114086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-04. Verfasst von Jianhong Liao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab of Biomaterials, CAS Key Laboratory of Biomedical Imaging Science and System, Institute of…. Hauptthemen laut MEDLINE: Interleukin-12, Probiotics, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab of Biomaterials, CAS Key Laboratory of Biomedical Imaging Science and System, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technol…
- National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, China. Electronic address: chentingtao1984@163.com.
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Chinese Academy of Sciences Shenzhen Institutes of Advanced Technology
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Natural Science Foundation of Guangdong Province
- China Postdoctoral Science Foundation
Zitieren
APA
Liao, J., Pan, H., Huang, G., Gong, H., Chen, Z., Yin, T., Zhang, B., Chen, T., Zheng, M., & Cai, L. (2024). T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1/IL-12 engineered probiotics. Cell Reports, 43(4), 114086. https://doi.org/10.1016/j.celrep.2024.114086
Vancouver
Liao J, Pan H, Huang G, Gong H, Chen Z, Yin T, et al. T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1/IL-12 engineered probiotics. Cell Reports. 2024;43(4):114086. doi:10.1016/j.celrep.2024.114086
BibTeX
@article{Liao2024,
author = {Liao, Jianhong and Pan, Hong and Huang, Guojun and Gong, Han and Chen, Ze and Yin, Ting and Zhang, Baozhen and Chen, Tingtao and Zheng, Mingbin and Cai, Lintao},
title = {T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1/IL-12 engineered probiotics},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {4},
pages = {114086},
doi = {10.1016/j.celrep.2024.114086}
}
EUVIMED